Get started
Author

Martin Kleman

Observed name: M. Kleman
ORCID: 0009-0000-0042-5269
Observed ORCID: 0009-0000-0042-5269
OpenAlex ID: A5093564928
The impact of relapse on patient disability, clinical outcomes, and subsequent burdens to patients with neuromyelitis optica spectrum disorder and caregivers
2026 · Saif Huda, Martin Kleman, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical
CO105 Extrapolation of Impact on Individual Patient Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD) Due to Relapse Reduction From Ravulizumab and Other Novel Biologic Treatments
2025 · Paulus S. Rommer, Martin Kleman, et al. · Value in Health
Patient Preferences for Treatment Features in Neuromyelitis Optica Spectrum Disorder (NMOSD): Results From a Discrete Choice Experiment (DCE) (P7-8.013)
2025 · Justin Abbatemarco, Jeffrey Yu, et al. · Neurology
Assessing the impact of relapses on patient outcomes in NMOSD
2024 · A. Kießlich, M. Kleman, et al. · Clinical Neurophysiology
PCR123 Assessing the Impact of Relapses on Burden to the Patient and Caregiver in NMOSD
2023 · M. Kleman, S. Tursunova, et al. · Value in Health
PDF
PCR177 Assessing the Impact of Relapses on Patient Outcomes in NMOSD
2023 · M. Kleman, S. Tursunova, et al. · Value in Health
PDF
Works count: 6
Citation count:
H-index:
I10-index:
Year
Topic
Type